These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2946989)

  • 1. [Treatment of acute and chronic venous pathology of the extremities. Effect of mesoglycan in a case study of 50 patients].
    Florio A; Rosati V; Cioffi G
    Minerva Med; 1986 Oct; 77(41):1933-5. PubMed ID: 2946989
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mesoglycan in acute and chronic venous insufficiency of the legs].
    Sangrigoli V; Carrà G; Lazzara N; Micale F; Puleo MG; Bonaccorsi R
    Clin Ter; 1989 May; 129(3):207-9. PubMed ID: 2527115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Instrumental evaluation of the effects of mesoglycan in venous disease patients. A prospective randomized double-blind study].
    de Donato G; Sangiuolo P
    Minerva Med; 1986 Oct; 77(41):1927-31. PubMed ID: 2946988
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of a minor fibrinolytic drug (mesoglycan) in phlebitis].
    Scondotto G; De Fabritiis A; Guastarobba A; Amato AC; Filippini M
    Minerva Med; 1984 Jul; 75(28-29):1733-8. PubMed ID: 6236381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of our experience in the use of mesoglycan in the therapy of acute and chronic venous diseases of the legs].
    Mangoni N; Righi D; Lucente E; Tonarelli AP; Lucarelli F; Borgioli F; Nuzzaci G
    Minerva Med; 1986 Oct; 77(41):1903-8. PubMed ID: 2946983
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological treatment of mechanical edema: a randomized controlled trial about the effects of mesoglycan.
    Viliani T; Scarselli M; Pieri A; Gatti M; Santini M; Pasquetti P
    Eur J Phys Rehabil Med; 2009 Mar; 45(1):21-9. PubMed ID: 19270639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of mesoglycan in patients with previous deep venous thrombosis and chronic venous insufficiency.
    Andreozzi GM
    Minerva Cardioangiol; 2007 Dec; 55(6):741-53. PubMed ID: 18091643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study of the efficacy of mesoglycan in the treatment of venous diseases of the legs].
    Vercelloni M; Cogo R; Furcolo F; Monzani G; Casali W; Di Franco G
    Clin Ter; 1985 Nov; 115(3):173-6. PubMed ID: 2935355
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical contribution to pharmacology in venous pathology and its complications. Effects of heparin in gel form].
    D'Amico N; Greco N; Ruotolo G; Colonna CV
    Minerva Cardioangiol; 1987 Apr; 35(4):195-203. PubMed ID: 3601108
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mesoglycan and phlebopathy. A clinico-experimental contribution].
    Allegra C; Bonifacio M; Riccioni C; Tonelli V
    Minerva Med; 1986 Oct; 77(40):1887-92. PubMed ID: 2946005
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mesoglycan and fibrinolysis: therapeutic activity of oral mesoglycan in venous thrombosis. A short-term clinical, biological and instrumental study].
    Vittoria A; Cappelli R; Messa GL; Auteri A
    Minerva Med; 1986 Oct; 77(40):1867-72. PubMed ID: 2946002
    [No Abstract]   [Full Text] [Related]  

  • 12. [Heparan sulfate: efficacy and safety in patients with chronic venous insufficiency].
    Agrati AM; De Bartolo G; Palmieri G
    Minerva Cardioangiol; 1991 Oct; 39(10):395-400. PubMed ID: 1839430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness of mesoglycan topical treatment of leg ulcers in subjects with chronic venous insufficiency].
    La Marca G; Pumilia G; Martino A
    Minerva Cardioangiol; 1999 Sep; 47(9):315-9. PubMed ID: 10630070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug therapy in chronic venous insufficiency].
    Becker D
    Z Allgemeinmed; 1973 Jun; 49(18):898-901. PubMed ID: 4728554
    [No Abstract]   [Full Text] [Related]  

  • 15. [Venous insufficiency of the legs. Pharmacologic treatment with glycosamine-glycan (Perclar)].
    Gossetti B; Gattuso R; Irace L; Aracu A; Intrieri F; Iacovino P; Massa R; Benedetti-Valentini F
    Minerva Med; 1986 Oct; 77(41):1915-8. PubMed ID: 2946986
    [No Abstract]   [Full Text] [Related]  

  • 16. A placebo-controlled, double-blind study of mesoglycan in the treatment of chronic venous ulcers.
    Arosio E; Ferrari G; Santoro L; Gianese F; Coccheri S;
    Eur J Vasc Endovasc Surg; 2001 Oct; 22(4):365-72. PubMed ID: 11563899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness of mesoglycan therapy in patients with ischemia of the lower limbs. Preliminary results of a new therapeutic protocol].
    Raso AM; Maggio D; Trogolo M; Rispoli P; Sandrone N; Pezzuto D; Bellan A; Melloni CD
    Minerva Cardioangiol; 1997; 45(7-8):383-92. PubMed ID: 9463174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of mesoglycan in venous pathology].
    Scondotto G; Catena G; Aloisi D
    Minerva Med; 1997 Dec; 88(12):537-41. PubMed ID: 9540785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic activity of oral mesoglycan in venous disease. A clinical and blood coagulation evaluation].
    Bracale GC; Selvetella L; Mirabile F; Ruocco A; Varriale V; De Caterina M
    Minerva Med; 1986 Oct; 77(41):1919-25. PubMed ID: 2946987
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sulodexide in the treatment of venous thrombosis].
    Penka M
    Vnitr Lek; 1995 Mar; 41(3):169-71. PubMed ID: 7762172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.